A. Shade, H. Peter, S. D. Allison, D. L. Baho, M. Berga et al., Fundamentals of microbial community resistance and resilience, vol.3, p.417, 2012.

D. G. Nimmo, R. Mac-nally, S. Cunningham, A. Haslem, and A. F. Bennett, Vive la résistance: Reviving resistance for 21st century conservation, Trends Ecol. Evol, vol.30, pp.516-523, 2015.

R. J. Derose and J. N. Long, Resistance and resilience: A conceptual framework for silviculture, Forest Sci, vol.60, pp.1205-1212, 2014.

S. D. Connell and G. Ghedini, Resisting regime-shifts: The stabilising effect of compensatory processes, Trends Ecol. Evol, vol.30, pp.513-515, 2015.

J. L. Funk, E. E. Cleland, K. N. Suding, and E. S. Zavaleta, Restoration through reassembly: Plant traits and invasion resistance, Trends Ecol. Evol, vol.23, pp.695-703, 2008.

C. S. Holling, Resilience and stability of ecological systems, Annu. Rev. Ecol. Syst, vol.4, pp.1-23, 1973.

L. C. Todman, F. C. Fraser, R. Corstanje, L. K. Deeks, J. A. Harris et al., Defining and quantifying the resilience of responses to disturbance: A conceptual and modelling approach from soil science, Sci. Rep, vol.6, p.28426, 2016.

S. D. Allison and J. B. Martiny, Resistance, resilience, and redundancy in microbial communities, Proc. Natl. Acad. Sci. U.S.A, vol.105, pp.11512-11519, 2008.

J. H. Jorgensen and M. J. Ferraro, Antimicrobial susceptibility testing: A review of general principles and contemporary practices, Clin. Infect. Dis, vol.49, pp.1749-1755, 2009.

A. Pai, Y. Tanouchi, and L. You, Optimality and robustness in quorum sensing (QS)-mediated regulation of a costly public good enzyme, Proc. Natl. Acad. Sci. U.S.A, vol.109, 2012.

N. Q. Balaban, J. Merrin, R. Chait, L. Kowalik, and S. Leibler, Bacterial persistence as a phenotypic switch, Science, vol.305, pp.1622-1625, 2004.

J. H. Jorgensen, J. D. Turnidge, M. A. Pfaller, K. C. Carroll, G. Funke et al., Manual of Clinical Microbiology, pp.1253-1273, 2015.

H. R. Meredith, J. K. Srimani, A. J. Lee, A. J. Lopatkin, and L. You, Collective antibiotic tolerance: Mechanisms, dynamics and intervention, Nat. Chem. Biol, vol.11, pp.182-188, 2015.

N. M. Vega and J. Gore, Collective antibiotic resistance: Mechanisms and implications, Curr. Opin. Microbiol, vol.21, pp.28-34, 2014.

M. E. Rupp and P. D. Fey, Extended spectrum b-lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment, Drugs, vol.63, pp.353-365, 2003.

J. T. Thaden, V. G. Fowler, D. J. Sexton, and D. J. Anderson, Increasing incidence of extendedspectrum b-lactamase-producing Escherichia coli in community hospitals throughout the Southeastern United States, Infect. Control Hosp. Epidemiol, vol.37, pp.49-54, 2016.

T. Coque, F. Baquero, and R. Canton, Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe, Euro. Surveill, vol.13, p.19044, 2008.

M. V. Villegas, J. N. Kattan, M. G. Quinteros, and J. M. Casellas, Prevalence of extended-spectrum b-lactamases in South America, Clin. Microbiol. Infect, vol.14, pp.154-158, 2008.

K. Bush, Beta-lactamase inhibitors from laboratory to clinic, Clin. Microbiol. Rev, vol.1, pp.109-123, 1988.

D. M. Livermore, beta-Lactamases in laboratory and clinical resistance, Clin. Microbiol. Rev, vol.8, pp.557-584, 1995.

A. J. Lee, S. Wang, H. R. Meredith, B. Zhuang, Z. Dai et al., Robust, linear correlations between growth rates and b-lactam-mediated lysis rates, Proc. Natl. Acad. Sci. U.S.A, vol.115, pp.4069-4074, 2018.

X. Y. Zhang, M. N. Trame, L. J. Lesko, and S. Schmidt, Sobol sensitivity analysis: A tool to guide the development and evaluation of systems pharmacology models, CPT: Pharmacometrics Syst. Pharmacol, vol.4, pp.69-79, 2015.

K. Bush and G. A. Jacoby, Updated functional classification of b-lactamases, Antimicrob. Agents Chemother, vol.54, pp.969-976, 2010.

P. Ball, The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections, Int. J. Antimicrob. Agents, vol.30, pp.113-117, 2007.

D. J. Weber, N. E. Tolkoff-rubin, and R. H. Rubin, Amoxicillin and potassium clavulanate: An antibiotic combination mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects, Pharmacotherapy, vol.4, pp.122-133, 1984.

P. H. Lebre, P. De-maayer, and D. A. Cowan, Xerotolerant bacteria: Surviving through a dry spell, Nat. Rev. Microbiol, vol.15, pp.285-296, 2017.

S. Lindquist and E. A. Craig, The heat-shock proteins, Annu. Rev. Genet, vol.22, pp.631-677, 1988.

A. J. Veraart, E. J. Faassen, V. Dakos, E. H. Van-nes, M. Lürling et al., Recovery rates reflect distance to a tipping point in a living system, Nature, vol.481, pp.357-359, 2012.

A. J. Manning and M. J. Kuehn, Contribution of bacterial outer membrane vesicles to innate bacterial defense, BMC Microbiol, vol.11, p.258, 2011.

C. A. Lozupone, J. I. Stombaugh, J. I. Gordon, J. K. Jansson, and R. Knight, Diversity, stability and resilience of the human gut microbiota, Nature, vol.489, pp.220-230, 2012.

W. J. Blake, G. Balázsi, M. A. Kohanski, F. J. Isaacs, K. F. Murphy et al., Phenotypic consequences of promoter-mediated transcriptional noise, Mol. Cell, vol.24, pp.853-865, 2006.

D. Nevozhay, R. M. Adams, E. Van-itallie, M. R. Bennett, and G. Balázsi, Mapping the environmental fitness landscape of a synthetic gene circuit, PLOS Comput. Biol, vol.8, p.1002480, 2012.

C. González, J. C. Ray, M. Manhart, R. M. Adams, D. Nevozhay et al., Stress-response balance drives the evolution of a network module and its host genome, Mol. Syst. Biol, vol.11, p.827, 2015.

B. G. Spratt, Resistance to antibiotics mediated by target alterations, Science, vol.264, pp.388-393, 1994.

T. D. Bugg, G. D. Wright, S. Dutka-malen, M. Arthur, P. Courvalin et al., Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA, Biochemistry, vol.30, pp.10408-10415, 1991.

T. Artemova, Y. Gerardin, C. Dudley, N. M. Vega, and J. Gore, Isolated cell behavior drives the evolution of antibiotic resistance, Mol. Syst. Biol, vol.11, p.822, 2015.

S. M. Drawz and R. A. Bonomo, Three decades of b-lactamase inhibitors, Clin. Microbiol. Rev, vol.23, pp.160-201, 2010.

, Augmentin XR NDA 50-785/S-006; Prescribing Information, 2005.

A. R. White, C. Kaye, J. Poupard, R. Pypstra, G. Woodnutt et al., Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: A review of the continuing development of an innovative antimicrobial agent, J. Antimicrob. Chemother, vol.53, pp.3-20, 2004.

R. C. Allen and S. P. Brown, Modified antibiotic adjuvant ratios can slow and steer the evolution of resistance: Co-amoxiclav as a case study, p.217711

, , 2017.

Y. Tanouchi, A. Pai, N. E. Buchler, and L. You, Programming stress-induced altruistic death in engineered bacteria, Mol. Syst. Biol, vol.8, p.626, 2012.

H. Fabre, N. H. Eddine, and G. Berge, Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin, J. Pharm. Sci, vol.73, pp.611-618, 1984.

J. Herman and W. Usher, SALib: An open-source Python library for sensitivity analysis, J. Open Source Softw, vol.2, p.97, 2017.

T. S. Kjeldsen, M. Overgaard, S. S. Nielsen, V. Bortolaia, L. Jelsbak et al., CTX-M-1 b-lactamase expression in Escherichia coli is dependent on cefotaxime concentration, growth phase and gene location, J. Antimicrob. Chemother, vol.70, pp.62-70, 2015.

J. Osuna, H. Viadiu, A. L. Fink, and X. Soberón, Substitution of Asp for Asn at position 132 in the active site of TEM b-lactamase activity toward different substrates and effects of neighboring residues, J. Biol. Chem, vol.270, pp.775-780, 1995.

J. T. Park and T. Uehara, How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol, Mol. Biol. Rev, vol.72, pp.211-227, 2008.

L. Poirel, M. Gniadkowski, and P. Nordmann, Biochemical analysis of the ceftazidimehydrolysing extended-spectrum b-lactamase CTX-M-15 and of its structurally related b-lactamase CTX-M-3, J. Antimicrob. Chemother, vol.50, pp.1031-1034, 2002.

H. Senn, U. Lendenmann, M. Snozzi, G. Hamer, and T. Egli, The growth of Escherichia coli in glucose-limited chemostat cultures: A re-examination of the kinetics, Biochim. Biophys. Acta, vol.1201, pp.424-436, 1994.

E. Tuomanen, R. Cozens, W. Tosch, O. Zak, and A. Tomasz, The rate of killing of Escherichia coli by b-lactam antibiotics is strictly proportional to the rate of bacterial growth, J. Gen. Microbiol, vol.132, pp.1297-1304, 1986.

H. Vu and H. Nikaido, Role of beta-lactam hydrolysis in the mechanism of resistance of a betalactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams, Antimicrob. Agents Chemother, vol.27, pp.393-398, 1985.

H. H. Wang, F. J. Isaacs, P. A. Carr, Z. Z. Sun, G. Xu et al., Programming cells by multiplex genome engineering and accelerated evolution, Nature, vol.460, pp.894-898, 2009.

X. C. Wu, W. Lee, L. Tran, and S. L. Wong, Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases, J. Bacteriol, vol.173, pp.4952-4958, 1991.